Ct Losartan / Hct (2017-09-01)

ACT Losartan / HCT Recall Summary ACT Losartan / HCT medication has been recalled across Canada due to product safety concerns. This is a Class I recall, indicating a serious issue. The recall affects all ACT brand Losartan / HCT products distributed in Canada.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-09-26

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/e51c1bb7-c2ec-4433-a285-66a01ba21c7d